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trials, English language. Study inclusion followed a review of the title,
abstract, and full text by two independent researchers.
Results: Two trends were identiﬁed. 1) DIEP ﬂap surgery reduces the risk
of abdominal weakness without increasing the risk of ﬂap complications if
performed by a surgeon well trained in microsurgery; 2) TRAM ﬂap sur-
gery remains a good alternative due to its evolution towards muscle-
sparing techniques.
Conclusion: This appears to be the ﬁrst systematic review in this area of
research. The evidence demonstrates that DIEP ﬂap reduces postoperative
abdominal morbidity, with no increased ﬂap complication compared to
the TRAM ﬂap if performed by a surgeon well trained in microsurgery.
0219: SCREEN DETECTED BREAST CANCERS CAN BE SAFELY AND
EFFECTIVELY MANAGED LOCALLY AS PREFERRED BY PATIENTS
R. Thomas a,*, E. Murdoch a, L. Smith a, S. Thompson a, A. Ramani b, M.
Alam b, D. Murphy b, J. Murray a, A. Lannigan a. aWishaw General Hospital,
UK; bMonklands General Hospital, UK
Aim: Currently screen-detected impalpable breast cancers are resected in
tertiary centres, often necessitating signiﬁcant journeys for patients. Our
patients express a preference for local surgery.
Methods: The management of impalpable breast lesions in our three
district general hospitals (DGHs) was audited to assess whether the sur-
gery could be performed locally.
All wide local excisions for breast lesions, which required localisation from
April 2010- August 2014 in the three breast units in Lanarkshire were
identiﬁed and included.
Results: 177 patients underwent pre-operative radiological localisation of
impalpable lesions. 81% of cases used ultrasound to place the wire with the
remainder requiring stereotactic localisation. The median specimen
weight was 34g (IQR 18.0e46.8g). All lesions were identiﬁed and removed
successfully. 142 (80%) patients had histological conﬁrmation of cancer or
DCIS. 33 patients (18%) required a second procedure due to involved or
close surgical margins.
Conclusion: Surgery for impalpable breast lesions can be performed
safely and effectively in our local DGHs. All lesions in this audit were
localised and excised. The number of patients requiring further surgical
procedures was similar to reported results from high volume centres. In
addition to inconveniencing patients, transferring patients between
health boards for treatment costs more and modiﬁcations to procedure
should be explored.
0241: NEGATIVE AXILLARY CLEARANCE IN SENTINEL NODE POSITIVE
BREAST CANCER
S.N. Rupasinghe*, R. Dean, R. Vinayagam, J.M. Lund, M. Callaghan, S.
Poonawala. Wirral University Teaching Hospitals NHS Foundation Trust, UK
Aim: NICE recommends axillary clearance (AC) for sentinel node positive
breast cancer. AC is associated with high morbidity. There was anecdotal
evidence that our rate of negative AC was high. We audited out practice to
investigate this.
Methods: All patients undergoing AC for positive sentinel node biopsies
(SNB) were identiﬁed for the one-year period starting 1st January 2013.
Data collected included tumour histology, pre-operative and post-opera-
tive staging. The Memorial Sloan Kettering (MSK) nomogram for predict-
ing further nodes was then applied retrospectively.
Results: 179 patients had SNB of whom 21 (median age 58 [range 30-77])
underwent AC for positive SNB.
Only 5(24%) had any further affected nodes in the AC specimen. There was
no direct relationwith any single variable for predicting further metastases
in the axillary specimen. However on the MSK nomogram, no patient who
scored below 15% had further nodes (p¼0.06 Fisher’s exact test, AUC ¼
0.791).
Conclusion: 76% of our patients did not beneﬁt from having AC. The
development of further metastases appears to be multifactorial and the
MSK nomogram might be useful in predicting this. Until the POSNOC trial
is ready to report, this area could be investigated further with a national
trainee research collaborative.0252: CONSIDERATIONS OF PACEMAKERS IN BREAST CANCER
MANAGEMENT
Be Pereira*, S. Waheed. East Surrey Hospital NHS Trust, UK
Aim: Cardiac pacemakers (PM) in the infraclavicular region of left chest
wall (1) can pose technical issues during treatments in breast cancer pa-
tients. We aim to raise awareness of the challenges in the management of
these patients.
Methods: Over one year April 2013e14, six breast cancer patients out of 75
diagnosed (8%) had pacemakers. All had triple assessment.
Results: 3 patients with left breast cancer had mastectomy. Bipolar
diathermy was used and breast tissue near the pacing wires was carefully
excised. One had radiotherapy necessitating moving the pacemaker to the
right. Another had right breast cancer and a left risk-reducing mastectomy.
Two further patients had right breast cancer requiring surgery followed by
radiotherapy and chemotherapy. All patients had recent Cardiac
assessment.
Conclusion: Breast cancer has been reported at the PM implanted site
therefore a thorough clinical examination is prudent (2,3). During surgery,
electromagnetic interference (EMI) caused by electrocautery, can cause
malfunction of the pacemaker and using bipolar diathermy will minimize
these effects (4). Radiotherapy, PET and MRI can cause EMI (5,6). It is
important to plan dosimetry towork out the radiation the PMmay receive.
Alternatively it may be necessary to move PM to the contralateral side.
Awareness of these issues with PM is needed.
0256: POSTOPERATIVE FOLLOW-UP PRACTICE OF PHYLLODES TUMOUR
IN THE UK: RESULTS FROM A NATIONAL SURVEY
A. Amer a,*, H. Mathers b. a James Cook University Hospital, UK; bCraigavon
Area Hospital, UK
Aim: Resected phyllodes tumours (PT) of the breast carry a small but
signiﬁcant risk of recurrence. Nevertheless, there are no national guide-
lines on postoperative follow-up of these tumours potentially resulting in a
wide variation in practice among breast surgeons in the UK.
Methods: A web-based questionnaire was sent to NHS breast surgeons
across the UK to assess individual follow-up practices including availability
of local guidelines, methods of follow-up and inﬂuence of risk factors.
Results: Only 38% from a total of 121 responses indicated the availability of
local guidelines on PT follow-up. Modal follow-up duration for borderline
and malignant disease was 5 years (53.7% and 79.3% of responses
respectively), compared to 1 year for benign disease (43%) although 28% of
respondents continue to review benign cases for 5 years. Less than 10%
offered patient-directed follow-up for benign and borderline disease.
Recurrent disease and margin status inﬂuenced the follow-up practice of
60% of respondents.
Conclusion: This survey highlights the wide variation in postoperative
follow-up for PT within the UK. This may affect the detection of disease
relapse or, conversely, result in wasted clinical resources and unnecessary
patient distress. Evidence-based national guidelines are necessary to
resolve this issue and inform best follow-up practice.
0265L: ATTITUDES TOWARDS BREAST CONSERVATION IN PATIENTS
AGED OVER 70 WITH BREAST CANCER
L. Smith*, S. Dayal, J. Murray, A. Lannigan. Wishaw General Hospital, UK
Aim: Investigate the attitudes of patients aged 70+ towards breast
conserving surgery (BCS) and factors which may inﬂuence their treatment
decisions.
Methods: A questionnaire was sent to patients aged 70+ at the time of
breast cancer surgery in NHS Lanarkshire between 1999 and 2013. This
detailed surgical recommendations, treatment expectations, and other
factors that may have inﬂuenced decision-making e.g. travel for radio-
therapy, potential side effects.
Results: Responses were received from 339 patients, 192 of whom had a
mastectomy, the remaining undergoing BCS. Eighty-six percent of both
groups were recommended their surgical management by the surgeon. In
the mastectomy group 18% would have preferred BCS had it been an
Abstracts / International Journal of Surgery 23 (2015) S15eS134S28option, with 40% willing to have neoadjuvant endocrine therapy to facili-
tate this. Only 14% would have considered neoadjuvant chemotherapy
with the same aim. Despite our BCS patients having to travel a consider-
able distance daily for radiotherapy, only 4% found it problematic. Eighty-
eight percent of patients who had BCS were happy with their treatment
decision, 72% being happy with the cosmetic outcome.
Conclusion: BCS is something that patients aged 70+ are interested in
considering. More than a third of mastectomy patients would be willing to
take neoadjuvant endocrine therapy to facilitate BCS.
0266: BREAST CANCER PRESENTATION IN THE OVER 70S
L. Smith*, J. Murray, A. Lannigan. Wishaw General Hospital, UK
Aim: To explore the presentation of the over 70s with breast cancer, along
with attitudes towards screening.
Methods: A questionnaire was sent to patients aged 70+ at breast cancer
diagnosis in NHS Lanarkshire between 2006 and 2013. This detailed rea-
sons and timing of presentation, in addition to thoughts about screening.
Results: Three hundred and ﬁfty-two questionnaires were sent with a 65%
response rate.
Sixty-four percent routinely examined themselves with 70% identifying a
lump themselves. Distressingly only 36% were aware of the other signs/
symptoms of breast cancer.
The majority of women sought medical attention early, with 39% pre-
senting within days, personal concern was the greatest prompt (68%).
Eighty-three percent routinely attended screening when invited, a further
3% willing to attend once over 70. The majority (60%) were not aware that
they could opt into the screening service when over 70.
Conclusion: Despite the belief that older women are less breast aware
most of our patients routinely examined themselves, identiﬁed pathology,
and promptly sought medical advice. Despite most women having no
knowledge of other signs and symptoms of breast cancer. Our cohort has
also shown that they are keen to continue screening over the age of 70 if it
was routinely offered.
0278: EVALUATING THE QUALITY OF INTERNET INFORMATION FOR
BREAST CANCER
A. Nghiem*, Y. Mahmoud, R. Som. Lewisham and Greenwich NHS Trust, UK
Aim: The internet is frequently used by patients for researching infor-
mation regarding breast cancer. Though much of it is contemporaneous
and of good quality, a signiﬁcant proportion of this information is un-
regulated, and potentially misleading. This study aims to assess the
quality of information on the internet regarding breast cancer using
validated tools.
Methods: The term 'breast cancer' was searched for in 3 search engines.
The top 20 results were selected and after duplicates and irrelevant
websites were excluded, the remaining websites were analysed using the
DISCERN Plus tool, HONcode and the JAMA benchmarks.
Results: 26 unique websites were assessed. The average score using the
DISCERN criteria was 57 out of a possible total of 80 e classed as ‘good’
(range: 25e74). Charity websites had the highest average score; 63 e
classed ‘excellent’. 9 websites were found to be HONcode certiﬁed. 7
websites complied with all four JAMA benchmarks.
Conclusion: This study shows the quality of breast cancer information on
the internet is on the whole good; however the range of quality is wide.
Patients may be heavily reliant on information available on the internet so
it is important for healthcare professionals involved in breast cancer care
to understand the nature of this information.
0290: AXILLARY STAGING IN BREAST CANCER: IMPROVEMENTS IN PRE-
OPERATIVE ULTRASOUND EVALUATION AT MUSGROVE PARK HOSPITAL
H. Weaver*, A. Brown, N. Atherton, S. Rahma, J. Gill, A. Thorne. Musgrove
Park Hospital, UK
Aim: NICE Guidelines (2009) advise that pre-treatment ultrasound eval-
uation of the axilla is undertaken for patients with early, invasive breast
cancer, and that ultrasound-guided needle sampling of any abnormalnodes should be performed. Pre-operative assessment of the axilla has
been standard practice at this unit since 2010. Our aim was to establish
whether rates of pre-operative diagnosis of axillary metastases have
changed since then.
Methods: Data were collected on all axillary procedures performed in
breast cancer patients between April 2010 and February 2014 at a busy
district general hospital. Cases were identiﬁed using consultant databases,
histopathology records and theatre diaries. Patients receiving neo-adju-
vant chemotherapy were excluded.
Results: 987 cases were identiﬁed. 279 patients had malignancy in the
axilla and 101 of these were diagnosed pre-operatively. The proportion of
patients with axillary malignancy diagnosed pre-operatively, as opposed
to using sentinel node biopsy, has increased year on year (21% in 2010-11;
37% in 2011e12; 48% in 2012e13 and 51% in 2013-14).
Conclusion: Over time, there has been a signiﬁcant trend towards diag-
nosing axillary malignancy pre-operatively rather than intra-operatively
on sentinel node biopsy. This suggests a learning curve in the use of
axillary ultrasound and node sampling in the unit.
0416: A RETROSPECTIVE ANALYSIS OF SURVIVAL AFTER BREAST
CANCER RECURRENCE: EVALUATION OF PREDICTIVE
CLINICOPATHOLOGICAL VARIABLES AND TREATMENT EFFECT
Y.K. Foo*, J. Byrne, R. Dave, E. Scott, Z. Kryjak, D. Ali. Pinderﬁelds General
Hospital, UK
Aim: To evaluate predictive clinicopathological variables of survival
following breast cancer recurrence.
Methods: All coded recurrences from January 2009 to January 2014
resulting from breast cancer resections from January 1988 to January 2013
were included in our study. Of the 272 patients identiﬁed, data was
available for 257 patients, and the clinicopathological variables were
analysed. The median follow-up was 9.40 years (IQR; 6.10e14.56). Survival
following recurrence was then calculated using log rank test.
Results: Survival following breast cancer recurrence was not predicted by
grade (p¼0.233), size (<50mm vs 50mm, p¼0.234) and hormone re-
ceptor status (ER+ve vs ER-ve; p¼0.873 and Triple negative; p¼0.224) of
the original tumour. There was no difference in the disease-free survival
between patients who developed distant and locoregional recurrence,
however, the overall survival following distant metastasis was 33.3
months, and that for locoregional disease was 54.6 months (n¼229,
p¼0.000). The majority of patients with locoregional disease (50/83) had
surgical management, and these patients had signiﬁcantly better post-
recurrence median survival (62 months) than those who had either
cytotoxic chemotherapy (33 months) or anti-hormone therapy (41
months).
Conclusion: Clinicopathological variables of the primary tumour cannot
predict recurrence; however aggressive surgical management of locore-
gional recurrence will improve survival compared to systemic therapy.
0451: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE INCIDENCE
AND PREDICTORS OF BLOOD TRANSFUSION IN BREAST
RECONSTRUCTION POST TRAM (TRANSVERSE RECTUS ABDOMINUS
MYOCUTANEOUS) FLAP AND DIEP (DEEP INFERIOR EPIGASTRIC
PERFORATOR) FLAP
S. Sepehripour a, G. Filobbos a,*, C. Malata b. aUniversity Hospital Coventry
and Warwickshire, UK; bAddenbrooke Hospital, UK
Aim: Despite the increase in number of women opting to have autologous
breast reconstruction with TRAM or DIEP ﬂaps, there is paucity in litera-
ture regarding the incidence and predictors of blood transfusion associated
with these procedures. The aim of the study is to conduct a systematic
review and meta-analysis of the incidence and predictors of blood trans-
fusion post TRAM and DIEP ﬂaps. To the best of our knowledge, this is the
only systematic review in literature on this topic.
Methods: Literature search conducted on Pubmed, Ovid medline and
EMBASE databases. Statistical analysis investigating odds ratio of trans-
fusion and correlation.
Results: The search identiﬁed 11 studies and no clinical trials. The reported
rate of transfusion ranges from 9.1% to 80.3% for DIEP and around 9% For
